Skip to main
ENTO
ENTO logo

Entero Therapeutics Inc (ENTO)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ENTO Stock

About Entero Therapeutics Inc (ENTO)

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Market cap$2.34M
Today's volume30.47K
Revenue (TTM)
Avg. daily volume1.53M
EBITDA (TTM)-$7.31M
Open$0.47
Price / earnings ratio-0.07x
Today's range$0.47 - $0.49
Debt / equity1.48x
52 week range$0.19 - $2.29
5 year debt / equity1.46x
Beta (LTM)-0.52x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.9x
Ex-dividend date
Next earningsApr 8, 2026
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for ENTO stock is $2.34M

The current P/E ratio for ENTO stock is -0.07

The 52-week high for ENTO stock is $2.29. The current ENTO stock price $undefined is 100.00% below its 52-week high

The 52-week low for ENTO stock is $0.19. The current ENTO stock price $undefined has increased 100.00% from its 52-week low

No, the ENTO stock does not pay dividends to its shareholders

How to buy ENTO stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ENTO stock

    Navigate to the Explore page. Then, type ENTO into the search bar. When you see ENTO stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ENTO stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Entero Therapeutics Inc Stock Earnings

The value each ENTO share was expected to gain vs. the value that each ENTO share actually gained.

ENTO (ENTO) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, ENTO's earnings per share (EPS) was $0. ENTO is expected to release next earnings on 04/08/2026, with an earnings per share (EPS) estimate of $0.

Buy ENTO Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.